Fortis Healthcare Limited (NSE:FORTIS)
India
· Delayed Price · Currency is INR 764.55
-8.90 (-1.15%)
Jul 11, 2025, 3:29 PM IST
Fortis Healthcare Revenue
In the fiscal year ending March 31, 2025, Fortis Healthcare had annual revenue of 77.83B INR with 12.91% growth. Fortis Healthcare had revenue of 20.07B in the quarter ending March 31, 2025, with 12.39% growth.
Revenue
77.83B
Revenue Growth
+12.91%
P/S Ratio
7.42
Revenue / Employee
6.44M
Employees
12,088
Market Cap
577.20B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 77.83B | 8.90B | 12.91% |
| Mar 31, 2024 | 68.93B | 5.95B | 9.45% |
| Mar 31, 2023 | 62.98B | 5.80B | 10.14% |
| Mar 31, 2022 | 57.18B | 16.87B | 41.87% |
| Mar 31, 2021 | 40.30B | -6.02B | -13.00% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 525.78B |
| Divi's Laboratories | 93.60B |
| Cipla | 272.67B |
| Mankind Pharma | 122.07B |
| Apollo Hospitals Enterprise | 217.94B |
| Zydus Lifesciences | 232.42B |
| Aurobindo Pharma | 317.24B |
| Glenmark Pharmaceuticals | 134.35B |
Fortis Healthcare News
- 3 months ago - Fortis Healthcare in focus: Subsidiary receives Rs 76.19 crore income tax demand for FY2019 - Business Upturn
- 3 months ago - Fortis Healthcare secures full ownership of ‘Fortis’ trademark for Rs 200 crore after Delhi High Court approval - Business Upturn
- 3 months ago - Pharma and hospital stocks in focus today: Alembic Pharma, Gland Pharma, Apollo Hospital, Fortis Healthcare, Dr Reddy’s [March 24, 2025] - Business Upturn
- 4 months ago - Fortis Healthcare receives injunction order related to Shrimann Hospital acquisition - Business Upturn
- 5 months ago - Fortis Healthcare subsidiary acquires Shrimann Superspecialty Hospital in Jalandhar for Rs 461.9 crore - Business Upturn
- 5 months ago - What to buy and sell today (February 10): M&M, SBI, Fortis among top picks, LIC & Ola Electric in focus - Business Upturn
- 5 months ago - Nomura on Fortis Health: Buy call, target at Rs 700, sees 8% upside on strong hospital revenue - Business Upturn
- 5 months ago - Fortis Healthcare Q3 FY25 results: Net profit jumps 89.4% YoY to Rs 254.3 Crore, revenue climbs 14.8% YoY - Business Upturn